Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAP-2 Activators

MAP-2, or microtubule-associated protein 2, is a cytoskeletal protein predominantly found in neurons, where it plays crucial roles in regulating microtubule dynamics and neuronal morphology. Functionally, MAP-2 is involved in stabilizing microtubules and promoting their assembly, thereby contributing to the structural integrity and organization of the neuronal cytoskeleton. Additionally, MAP-2 serves as a scaffolding protein, interacting with various cytoskeletal elements, signaling molecules, and membrane proteins to coordinate diverse cellular processes essential for neuronal function, including neurite outgrowth, synaptic plasticity, and intracellular transport. Given its pivotal role in maintaining neuronal structure and function, dysregulation of MAP-2 has been implicated in various neurological disorders, including Alzheimer's disease, schizophrenia, and bipolar disorder.

Activation of MAP-2 involves intricate regulatory mechanisms that modulate its interactions with microtubules and other cellular components. One major mechanism of MAP-2 activation involves phosphorylation by various protein kinases, including cyclin-dependent kinases (CDKs), glycogen synthase kinase 3 (GSK-3), and calcium/calmodulin-dependent protein kinase II (CaMKII). Phosphorylation of MAP-2 alters its conformation and promotes its binding to microtubules, enhancing microtubule stability and assembly. Additionally, post-translational modifications such as acetylation and methylation have been implicated in regulating MAP-2 activity by influencing its interactions with microtubules and other binding partners. Furthermore, MAP-2 activity can be modulated by intracellular signaling pathways activated by extracellular cues, such as growth factors and neurotransmitters, which converge on downstream effectors that regulate MAP-2 phosphorylation and function. Overall, the activation of MAP-2 is a tightly regulated process essential for maintaining neuronal cytoskeletal integrity and function, highlighting its significance in neuronal physiology and pathology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels which can influence MAP-2 expression and stability.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

PDE4 inhibitor that increases cAMP levels, promoting MAP-2 phosphorylation and stabilization.

Calmodulin (human), (recombinant)

73298-54-1sc-471287
1 mg
$300.00
(0)

Binds calcium ions and can influence MAP-2 interaction with microtubules.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Destabilizes microtubules, leading to increased interaction between MAP-2 and free tubulin.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules, which can facilitate MAP-2 binding.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Protein phosphatase inhibitor that can promote MAP-2 phosphorylation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor that can increase MAP-2 acetylation, affecting its activity.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

Protein kinase A inhibitor, alters PKA signaling that can affect MAP-2 phosphorylation.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$96.00
$264.00
2
(2)

Calcium ionophore, increases intracellular calcium levels that can influence MAP-2 activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Increases intracellular calcium levels, potentially affecting MAP-2 activity.